The transforming growth factor β1 (TGFβ1) is a major regulator of human endometrial function. Human endometrium possesses specific opioid binding sites, the majority of which belong to the kappa type, for which the prodynorphin-derived opioids are the endogenous ligands. Since these two systems interact in several other tissues we postulated that opioids may affect the production of TGFβ1 in human endometrium. We have found that kappa opioids exerted a time-and dose-dependent inhibitory effect on TGFβ1 production from endometrial stromal and epithelial cells and from the Ishikawa human endometrial adenocarcinoma cell line. This effect was reversible by the specific opioid antagonist diprenorphine. To examine if this effect represents a paracrine endometrial response to locally produced kappa opioids we searched for the presence of the endogenous kappa opioid receptor ligands. Indeed, the prodynorphin transcript was detectable on Northern blots from normal and tumoral human endometrial cells; its size was that of the pituitary transcript, i.e.~2.4 kb long. Most immunoreactive dynorphin from human endometrium had a molecular weight of 8 kDa. Finally, immunofluorescence staining of normal and tumoral human endometrial cells revealed the presence of dynorphin-positive cytoplasmic secretory granules. Taken together, our data suggest that in human endometrium, kappa opioids and the TGFβ1 form a paracrine network which appears to be retained by the Ishikawa human endometrial adenocarcinoma cell line.
Introduction
predominant type, while κ-opioid receptors are present in lower numbers and the κ-type of receptors are not detectable Multiple lines of evidence suggest that the transforming (Hatzoglou et al., 1995a) . growth factor (TGF) is an important modulator of endometrial Since these two systems interact in several other tissues we physiology involved in the regulation of endometrial growth, postulated that opioids may affect the production of TGFβ1 proliferation, and differentiation (Godkin and Dore, 1998) .
in human endometrium. Indeed in rat brain, κ-opioids are coIndeed, endometrial TGFβ1 affects the proliferation of normal localized and interact with TGFα and β (Code et al., 1987 ; human epithelial and stromal endometrial cells as well as the Ramirez-Ordonez et al., 1999) . Furthermore, κ-opioids proliferation of the human endometrial adenocarcinoma cell stimulate the release of TGFβ from human peripheral blood line Ishikawa (Croxtall et al., 1992; Tang et al., 1994 ; Albright mononuclear and porcine immune cells (Chao et al., 1992; and Kaufman, 1995) . Following ovulation, TGFβ1 stimulates Zhou et al., 1992) . The effects of opioids on TGF are not stromal cell proliferation, while at the same time inhibiting unique but they are rather part of a more generalized effect of endometrial epithelial cellular mitosis promoting their differenopioids on growth factors. Thus, it has been shown that tiation to the characteristic mature cells of the secretory synthetic κ-opioid agonists can interact with nerve growth endometrium (Marshburn et al., 1994) . In addition, TGFβ1 factor (NGF) in the rat pheochromocytoma cells (Margioris promotes apoptosis of endometrial stromal cells at the implantaet al., 1992) ; inhibit macrophage-colony stimulating factor tion site in an effort to accommodate the developing trophoblast (M-CSF) in mouse bone marrow cells (Roy et al., 1991) ; and in a hospitable implantation chamber (Moulton, 1994) .
modulate the biological effects of epidermal growth factor Human endometrium produces opioids and their receptors (EGF) in monkey kidney cells (Belcheva et al., 1998) . suggesting that endometrial opioids exert local, autocrine/
In the first part of this study, we examined the effect of paracrine, effects. Indeed, transcripts of endogenous opioid synthetic opioid agonists and antagonists on the production of precursors proopiomelanocortin (POMC) and proenkephalin TGFβ1 by normal human endometrial cells and the Ishikawa (PENK) and their end products have been reported in human human endometrial adenocarcinoma cell line. In the second endometrial cells (Walhstrom et al., 1985, Petraglia et al., part (following our data showing a specific effect of κ-opioid 1986, Makrigiannakis et al., 1992) . Multiple types of opioid agonists on endometrial TGF), we examined whether the binding sites have been identified in human endometrial cells, with the kappa (κ)-opioid receptor (κ1, κ2, κ3) being the endogenous ligands for the κ-opioid receptors are produced in data suggest that κ-opioids and TGF interact in a paracrine
The sensitivity of the assay is 7 pg/ml. Results were expressed as mode at the level of human endometrium.
pg/ml per µg of total cellular protein, determined on whole cellular homogenates by the Bradford method (Bradford, 1976) , using BSA as standard.
Materials and methods

Primary culture of isolated epithelial and stromal cells from Northern blot analysis human endometrium
Total RNA was extracted from frozen tissues or cultured cells by the Endometrial specimens were obtained from patients undergoing guanidine thiocyanate method (Maniatis et al., 1989) . Following sizediagnostic curettage or hysterectomy. Full ethics committee approval fractionation of RNA (50 µg/lane) by electrophoresis through 1.5% had been granted for this study. The histological type and pathology of agarose gels containing 6% formaldehyde and 2 µg/ml ethidium the biopsies was confirmed by conventional pathological examination.
bromide, gels were viewed under UV light to assess the integrity. Purified epithelial and stromal primary endometrial cell cultures After transfer to GeneScreen nylon filters (New England Nuclear, were established as described previously (Chatzaki et al., 1994;  Boston, MA, USA), they were prehybridized and hybridized as Makrigiannakis et al., 1995) . Briefly, the tissues were collected in previously described (Maniatis et al., 1989) . A synthetic 48-mer Dulbecco's minimal essential medium (DMEM; Gibco BRL, oligonucleotide against bases 36-83 of the rat prodynorphin (PDYN) Bethesda, MD, USA) supplemented with 10% fetal calf serum mRNA (this area of mRNA is identical in both humans and rats) (FCS) and 1% antibiotic/antimycotic solution, trimmed and minced (Douglass et al., 1989) was used as a probe that was labelled at the mechanically and digested for 90 min at 37°C using 0.25% of Type 3Ј end with [γ-32 P]-deoxyadenocine triphosphate (800 Ci/mmole; I collagenase (Sigma Chemical Co, St Louis, MO, USA). Separation
Amersham, Arlington, IL, USA) and terminal deoxynucleotidyl transof the epithelial and stromal fraction was carried out by filtration ferase (BRL, Bethesda, MD, USA) to a specific activity of~10 8 dpm/ through a 45 µ stainless steel sieve and backwashing of the glands mg. Blots were washed in 0.2ϫ SSC, 0.1% SDS for 30 min at 60°C. from the sieve, followed by pelleting by centrifugation. The two Autoradiography using Kodak XR film took place at -70°C in the different cell types were then plated in 24-well plates (Corning Inc, presence of an intensifying screen. The approximate size of mRNAs New York, NY, USA) with 1 ml of culture medium and incubated in was determined relatively to 18S and 28S rRNAs. a humidified atmosphere of 5% CO 2 at 37°C, in the above mentioned medium for 2 days before experimentation. At the beginning of the Gel filtration chromatography and radioimmunoassay for dynorphins experiment, cultures had reached 100% confluency and at least 90% purity in epithelial or stromal cell content, as judged by light Peptides in Ishikawa cell culture medium and endometrial homogenmicroscopy. Following this, they were pre-incubated in Phenol ates were concentrated by a C-18 reverse phase column (Sep-Pak; Red-and serum-free Roswell Park Memorial Institute (RPMI) 1640
Waters Associates, Milford, MA, USA). Briefly, culture media and medium (Biochrom Co, Berlin, Germany) supplemented with 0.25% cellular homogenates were acidified by 10 volumes of 0.1 N HCI bovine serum albumin (BSA) fraction V (Sigma), insulin from bovine and centrifuged at 5000 g for 10 min. The supernatants were extracted pancreas (5 mg/l), transferin (5 mg/l) and sodium selenite (5 ng/l) by activated Sep-Pak cartridges, washed with 20 ml 0.1 N HCl, (ITS cell culture supplement, Sigma), 2 mmol/l L-glutamine and 1% eluted with 3 ml acetonitrile 80%-0.01% HCI, then dried under antibiotic/antimycotic solution for 24 h. The κ 1-opioid receptor vacuum (Speed-Vac). The recovery of synthetic dynorphin diluted in agonist U69593 (Upjohn Co, Kalamazoo, MI, USA) and/or the medium using this method was Ͼ90%. Samples were then reconstitgeneral opiate antagonist diprenorphine (Sigma) were then added in uted in 0.5 ml 10% formic acid containing 0.5% defatted BSA and the above medium in duplicate or triplicate wells, in parallel with 6 mol/l urea and chromatographed on a Sephadex G-50 column non-treated controls.
(0.9ϫ60 cm, bed volume 40 ml). The G-50 column was calibrated with blue dextran and dynorphin- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . With flow rate 1.5 ml/h, Culture of the Ishikawa endometrial cell line fractions of 1 ml were collected, dried under vacuum and reconstituted Ishikawa cells were established as a permanent cell line from a well for radioimmunoassay using an antiserum raised against synthetic differentiated human endometrial adenocarcinoma (Nishida et al., , which is identical to human dynorphin-(1-13) 1979; Gravanis and Gurpide, 1986) . The cells were routinely cultured (Suda et al., 1983; Margioris et al., 1992) . The antiserum cross-reacts in 75 ml cell culture flasks (Corning) in Earle's minimal essential with human dynorphin-(1-13) and dynorphin A. It exhibits no crossmedium (Gibco) supplemented with 15% fetal bovine serum (FBS; reaction with synthetic human β-endorphin, neo-endorphin, or Gibco), 10 mmol/l L-glutamine and 1% antibiotic-antimycotic met-or leu-enkephalin. The sensitivity of the assay was 1 pg/tube. solution (Gibco) to a final concentration of 100 IU/ml penicillin and Indirect immunofluorescence 100 µg/ml streptomycin, in a humidified atmosphere of 5%CO 2 at 37°C. Cells growing exponentially were seeded into 24-well plates
Immunofluorescence staining was performed as described previously (Corning) (25ϫ10 3 cells/well) and incubated for 24 h in 1 ml growth (Fostinis et al., 1992) . Briefly, cells grown on 22ϫ22 mm coverslips medium. Before drug treatment, cells were placed in serum-free, in absence of serum were fixed with acetone/methanol (9:1) for Phenol Red-free medium as mentioned above.
20 min. The cells were then incubated for 1 h at 4°C with rabbit antiserum against human dynorphin, diluted 1:250 in phosphateMeasurement of TGFβ1 buffered saline (PBS) 0.1% BSA (Margioris et al., 1992) in parallel with a negative control (PBS 0.1% BSA). After washing, an antiAt the end of the treatment period, cell culture supernatants were collected and stored at -70°C for TGFβ1 measurement, whereas cells rabbit antibody conjugated to fluorescein isothiocyanate (FITC) was added (1:150, Amersham) for 1 h at 4°C. Specimens were visualized were harvested in a standard trypsin solution (Gibco) and stored at -20°C for estimation of protein content. TGFβ1 was measured using in a Zeiss Axioscope microscope and photographed using TMZ 135-36 Kodak film. a human TGFβ1 Quantikine immunoassay kit (R&D Systems, Oxon,
Statistical analysis
Data of TGFβ1 concentrations are presented either as pg/ml per µg of protein or as percentage of non-treated controls. For the statistical analysis of the results we used analysis of variance followed by posthoc comparison of means and least significant difference test or planned comparison. All analyses were carried out on combined results from at least three identical experiments, performed in duplicate or triplicate.
Results
Effects of opioid agonists and antagonists on TGFβ1 production from primary cultures of human endometrial cells
Purified primary cultures were established after isolation of the respective cellular fraction from endometrial biopsies, obtained from patients undergoing diagnostic curettage. As we have previously reported, our method provides a pure population of isolated epithelial or stromal monolayers, with little contamination from other uterine cell types (Makrigiannakis et al., 1995) . We investigated TGFβ1 production from epithelial and stromal cell primary cultures of human endometrium together with the effect of κ-opioid peptides on endometrial TGFβ1. For this purpose, the use of synthetic opioid receptor ligands was preferred to dynorphin peptides, due to their stability in vitro. U69593 is a non-peptidic synthetic molecule that exhibits specific agonist activity on κ 1 -opioid receptors 2 days were expressed as pg/µg of protein Ϯ SEM, and were 14.97 Ϯ 5.27 for proliferative epithelium (PE, n ϭ 7), further explored the observed effect in time-and dose-response 10.62 Ϯ 2.66 for secretory epithelium (SE, n ϭ 5), 146.73 Ϯ experiments, using cells from both phases of the cycle ( Figure  52 .21 for proliferative stroma (PS, n ϭ 4) and 61.26 Ϯ 14.15
2). Time-response curves (Figure 2A) showed that the statisticfor secretory stroma, (SS, n ϭ 5) ( Figure 1A) . It is noted that ally significant reduction of TGF-β1 secretion by U69593 was the stromal fraction secreted higher levels than the glandular abolished after 6 days of culture of epithelial cells and 4 days in both phases of the cycle. This finding corroborates with of culture for stromal cells. Thus, 2-day treatment was chosen other reports showing that stroma is the principal source of for all the following experiments. Also, it was noticed that TGFβ1 in the uterine cavity (Chegini et al., 1994; Marshburn basal release of TGFβ1 decreased during the 6 days of culture, et al., 1994) .
probably reflecting a decrease in the number of viable cells, due to prolonged incubation in serum-free medium with no Effect of opioid agonists and antagonists on TGFβ1 oestrogen supply that cannot support endometrial growth for production from human endometrium cells in culture long. However, the use of this medium was necessary, because serum contains measurable levels of TGFβ1, as well as other Incubation of various endometrial cell types with 10 -7 mol/l U69593 caused a significant reduction in the concentration of growth factors and steroid residues that could affect the regulation of TGFβ1 expression (Gutierrez et al., 1998) . Dose-TGFβ1 in the culture supernatant of almost all primary cultures ( Figure 1B) . Indeed, this effect was observed in seven out of response curves were biphasic for both stromal and epithelial cells ( Figure 2B ). An inhibitory effect of U69593 was observed seven of PE, three out of five SE, four out of four PS and four out of five SS. As shown in Figure 1 , the inhibitory effect at 10 -10 mol/l (0.1 nmol/l) and at 10 -8 and 10 -7 mol/l (10 and 100 nmol/l), but not at 10 -9 mol/l (1 nmol/l). When further of the opioid agonist was at much the same level (52 Ϯ 9 to 69 Ϯ 5% of non-treated controls) in all types of cells. We dilutions of the drug were tested, it was shown that the Ishikawa human endometrial cells. Cells were treated with U69593 absence of the opioid antagonist diprenorphine (Dipr, 10 -6 mol/l) (A and C 10 -7 mol/l and B), in the absence or presence of the (C) in parallel with non-treated controls and the concentration of general opioid antagonist diprenorphine (Dipr, 10 -6 mol/l) (C) in TGFβ1 was measured in the culture media after 2, 4 and 6 days of parallel with non-treated controls and the concentration of TGFβ1 treatment (A), or just on the second day (B and C). The bars was measured in the culture medium after 2, 4 and 6 days of represent the mean values of three experiments from different treatment (A), or just on the second day (B and C). The bars endometria, expressed as a percentage of non-treated controls and represent the mean values of three identical experiments expressed the error bars show the standard errors between replicates. E ϭ as a percentage of non-treated controls and the error bars show the epithelial cells; S ϭ stromal cells. *Statistically significant standard errors between replicates. *Statistically significant differences (P Ͻ 0.05).
differences (P Ͻ 0.05).
inhibitory effect was abolished in the nanomolar concentrations of U69593 ranging from 2ϫ10 -10 to 10 -9 mol/l, whereas in opioid receptors. It is interesting to note that treatment with diprenorphine alone increased TGFβ1 secretion in a statistically 2ϫ10 -9 mol/l the effect was statistically significant (data not shown). As discussed later, this interesting profile probably significant way, suggesting that the action of exogenously produced opiods is blocked. reflects interaction of the ligand with multiple types of opioid or other receptors. In order to test whether the observed effect Effect of opioid agonists and antagonists on TGFβ1 is mediated through specific opioid receptors, we measured production from Ishikawa human endometrial TGFβ1 release after 2 days of treatment of various endometrial adenocarcinoma cells in culture cell types with U69593 (10 -7 mol/l) in the presence or absence of a ten-fold excess of the opioid antagonist diprenorphine Ishikawa cells were treated with U69593 (10 -7 mol/l) and the concentration of TGFβ1 was measured in the culture media (10 -6 mol/l). Diprenorphine was chosen due to its general opioid receptor antagonistic activity compared with the more after 2, 4 and 6 days of treatment. The combined results of three identical experiments are illustrated in Figure 3A . A often used naloxone, a µ-preferential antagonist (Billington et al., 1990) . Naloxone has also been reported to exhibit also statistically significant reduction of the concentration of TGFβ1 was observed, with a maximum of 52.02 Ϯ 5.26% of nonagonist activity (Cruz et al., 1996) . As shown in Figure 2C , the inhibition caused by U69593 was reversed in the presence treated control (P Ͻ 0.05) on the second day of treatment.
The effect remained similarly profound after 4 and 6 days of of the antagonist, diprenorphine, suggesting action through
Characterization and localization of dynorphin in human endometrial cells
To identify the type of immunoreactive material that is the end product of the PDYN mRNA expressed in endometrial cells, normal endometrial cell homogenates and culture supernatant from Ishikawa cells were concentrated and analysed by gel filtration chromatography. The bulk of immunoreactive material eluted from the chromatography exhibited the molecular weight of the 8 kDa form of dynorphins, while small quantities of a 4 kDa peptide was also detectable in culture media from Ishikawa cells ( Figure 4B ). It is interesting that the chromatographic profile from both sources exhibits a very similar profile, confirming the resemblance of the Ishikawa cell line behaviour to the original tissue. in the cytoplasm, where well-demarcated positive granules were observed. There was a marked concentration of immunoreactive material in the peri-nuclear area in both preparations, whereas nuclei were negative. Preparations from normal and treatment (55.57 Ϯ 6.30 and 56.64 Ϯ 7.53 respectively, P Ͻ tumoral epithelial cells revealed the same pattern of expression. 0.05). The dose-response curve of this effect, measured after Isolated stromal cells from primary endometrial cultures 2 days of treatment, is presented in Figure 3B . The profile of showed also weak cytoplasmic staining for dynorphin (Figure the curve was biphasic, confirming the results from the primary 5F), compared with the negative control ( Figure 5E ). cultures of endometrial cells. Indeed, although we were able to detect a significant decrease in concentrations as low as 10 -12 mol/l (0.001 nmol/l), at the concentration of 10 -9 mol/l
Discussion
(1 nmol/l), the effect was abolished. Finally, we measured Several reports suggest that opioid peptide agonists modulate TGFβ1 release after 2 days of treatment with U69593 the production and/or effects of growth factors in a paracrine (10 -7 mol/l) in the presence or absence of a 10-fold excess of manner. Thus, the endogenous κ-opioid agonist, dynorphin, the opioid antagonist diprenorphine (10 -6 mol/l). As shown in inhibits the effect of macrophage-colony stimulating factor Figure 3C , the inhibition caused by U69593 was reversed in (M-CSF) on mouse bone marrow cells (Roy et al., 1991) . the presence of the antagonist, suggesting action through opioid Similarly, the synthetic κ-opiod agonist U-69593 inhibits the receptors. It is interesting to note that treatment of Ishikawa proliferative effect of epidermal growth factor (EGF) on PC12 cells with diprenorphine alone increased TGFβ1 secretion in rat pheochromocytoma cells (Venihaki et al., 1996) . U69593 a statistically significant way (148.05 Ϯ 8.48% of non-treated also affects the EGF-dependent modulation of extracellular control, P Ͻ 0.05), suggesting that the antagonist blocked the signal-regulated protein kinase in monkey kidney cells action of endogenously produced opioids. (Belcheva et al., 1998) . µ-opioid agonists stimulate the release of TGFβ from human peripheral blood mononuclear and Detection of the PDYN transcript in human porcine immune cells (Chao et al., 1992 , Zhou et al., 1992 ) endometrial cells and in rat brain they are co-localized and interact with TGF α and β (Code et al., 1987; Ramirez-Ordonez et al., 1999) . In order to examine the expression of the PDYN gene by endometrial cells, preparations of total RNA from normal Human endometrium is a typical example of a tissue where opioids and growth factors co-exist side-by-side. TGFβ1 rephuman secretory endometrial biopsy and Ishikawa cells, were subjected to Northern blot hybridization analysis using a PDYN resents a major endometrial growth factor (Godkin and Dore, 1998) . Indeed, TGFβ1 affects the proliferation of epithelial mRNA probe. In parallel, total RNA isolated from rat pituitary and rat liver was used as positive and negative controls and stromal cells of normal and tumoral human endometrium (Croxtall et al., 1992; Marshburn et al., 1994; Tang et al., respectively. Figure 4A depicts the autoradiography of Northern blots revealing the presence of PDYN transcripts in RNA 1994, Albright and Kaufman, 1995) . It should be noted that TGFβ1 also enhances the apoptosis of normal endometrial extracted from endometrial sources (lanes 3 and 4), the size of which was~2.4 kb long, similar or identical to this detected stroma (Moulton, 1994) . Based on the above data we postulated that opioids may affect TGFβ1 production in human endometin the rat pituitary (lane 1, positive control). The probe used did not hybridize with total RNA isolated from rat liver (lane 2, rium. The bulk of opioid binding sites in normal and tumoral human endometrium are of the κ1 type. Based on this data, negative control). we used a specific κ1-opioid receptor agonist, U69593. We of several neuropeptides regulating endometrial growth and differentiation via modulation of local growth factors. TGFβ1 have found that U69593 had a consistent inhibitory effect on TGFβ1 production from endometrial cells obtained from appears to be such a factor regulating the proliferation of both epithelial and stromal endometrial cells as well as that of the biopsies of proliferative and secretory endometrium. This inhibitory effect was equally demonstrable in epithelial as well Ishikawa cells (Croxtall et al., 1992; Tang et al., 1994; Albright and Kaufman, 1995) . Furthermore, TGFβ1 stimulates stromal as stromal cells and on the epithelial cells of the Ishikawa cell line. This effect appeared to be specifically mediated by opioid cell proliferation preparing the endometrium for placental implantation while, at the same time, inhibiting epithelial receptors since the general opioid antagonist, diprenorphine, reversed it. Interestingly, the dose-response curves of TGFβ1 mitosis and promoting their differentiation (Marshburn et al., 1994) . TGFβ1 also stimulates the apoptosis of endometrial were bell-shaped, showing an attenuation of this effect of U69593 at nanomolar concentrations. This type of response stroma (Moulton, 1994), a mechanism responsible for the degeneration of antimesometrial decidua that enables trophoto opioids has been described in other systems (Yamaguchi et al., 1998) . It may reflect the low affinity that each 'specific' blast development and remodelling of the implantation chamber. Opioids have been shown to affect cell proliferation. opioid agonist has towards other types of opioid receptors as well as to the competition of exogenous synthetic opioids to Thus, it has been reported that they inhibit lung cancer (Maneckjee and Minna, 1990 ) and PC12 rat pheochromocyendogenous opioid agonists, or even other endometrial factors, e.g. interleukin-6, that can activate opioid receptors (Wang toma cell proliferation (Venihaki et al., 1996) while preventing their apoptosis (Dermitzaki et al., 2000) , and in human prostate et al., 1996) . Furthermore, it has been suggested that at high concentrations, opioids may also bind to completely different cancer cells they stimulate cell proliferation (Moon, 1988) . In addition, opioid peptides inhibit the action of oestradiol on receptors (Hatzoglou et al., 1995b) . Experiments conducted using Ishikawa cells transiently transfected with the TGFβ1 human myometrial cells (Kornyei et al., 1999) . It is possible that at least some of these effects of opioids are mediated by promoter linked to the luciferase reporter gene have shown that treatment of the transfectants with U69593 had no effect locally produced growth factors affected by opioids in a paracrine manner. Indeed, in the present study, we report the on luciferase expression suggesting that the effect of opioids is post-transcriptional (data not shown). Our data are in expression of the main endogenous ligand for the κ opioid receptors, the dynorphin, in normal and tumoral human endoagreement with reports showing that steroids and retinoids regulate TGFβ1 at a post-transcriptional level (Kim et al., metrial cells. More specifically, we have found that the PDYN gene transcripts and their protein end-product dynorphin are 1992). Indeed, it has been suggested that a stem-loop which is formed in the 5Ј-untranslated region of the TGFβ1 transcript detectable in both types of cells. On Northern blot analysis the size of the transcript is 2.4 kb in size, which is similar or may represent a possible target of the κ opioids which may, thus, suppress translation (Romeo et al., 1993) .
identical to that present in other tissues including rat pituitary and adrenals. The size of the immunoreactive material was The paracrine effect of κ opioids on TGFβ1 in human endometrium may be part of a larger network composed~8 kDa, a finding which confirmed our hypothesis. Localization
